Clinical and hemodynamic effects of carvedilol in patients with hypertrophic cardiomyopathy
Aim. To study carvedilol effectiveness in patients with hypertrophic cardiomyopathy (HCMP). Material and methods. The study included 52 patients with HCMP (67% men and 33% women; mean age 40,7±3,1 yeas). All participants underwent clinical examination, six-minute walk test (6mwt), standard 12-lead e...
Saved in:
Main Authors: | T. A. Abdullaev, O. Kh. Allaberganov, B. U. Mardanov, R. D. Kurbanov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
1970-01-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2064 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LEFT VENTRICULAR WALL THICKNESS AND AUTONOMIC REGULATION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
by: O. Allaberganov, et al.
Published: (2011-10-01) -
Clinical features of hypertrophic cardiomyopathy depending on the hereditary factor
by: V. G. Davydova, et al.
Published: (2023-08-01) -
Сlinical features of hypertrophic cardiomyopathy depending on the age of onset of clinical manifestations and the presence of cardiometabolic risk factors
by: V. G. Davydova, et al.
Published: (2023-05-01) -
AMIODARONE THYROTOXICOSIS IN A PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY
by: P. Kh. Dzhanashiya, et al.
Published: (2009-06-01) -
Infective Endocarditis in Patients with Hypertrophic Cardiomyopathy
by: E. Yu. Ponomareva, et al.
Published: (2021-09-01)